The company said it reaffirmed its fiscal 2025 full-year Adjusted Earnings per Diluted Share guidance in the range of $31.75 to $32.55 during its webcast at the Wells Fargo 2024 Healthcare Conference on September 5, 2024.

1. 01

   The company said it reaffirmed its fiscal 2025 full-year Adjusted Earnings per Diluted Share guidance in the range of $31.75 to $32.55 during its webcast at the Wells Fargo 2024 Healthcare Conference on September 5, 2024.

2. 02

   The company also said it anticipates fiscal 2025 Q2 Adjusted earnings per Diluted Share will be in the range of $6.70 to $7.00 during the same webcast.

3. 03

   The company said it calculates Adjusted Earnings per Diluted Share by excluding from GAAP earnings per diluted common share attributable to McKesson the effects of acquisition-related intangible amortization, LIFO inventory-related adjustments, and restructuring, impairment and related charges, along with the related income tax effects of these items.

4. 04

   The company said it does not provide GAAP-basis outlook because it cannot provide a quantitative reconciliation of its non-GAAP outlook measures to the most directly comparable GAAP outlook measures without unreasonable effort. It said LIFO inventory-related adjustments and similar items cannot reasonably be forecast.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.